Journal
/
Medicine
/
Infusion IV continue est le traitement de choix pour la route Arginine-vasopressine Receptor Blocker Conivaptan chez des souris pour étudier des maladies évoqués Oedème cérébral…
JoVE Journal
Medicine
Medicine
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Infusion IV continue est le traitement de choix pour la route Arginine-vasopressine Receptor Blocker Conivaptan chez des souris pour étudier des maladies évoqués Oedème cérébral
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/54170-v
•
08:44 min
•
September 1st, 2016
Infusion IV continue est le traitement de choix pour la route Arginine-vasopressine Receptor Blocker Conivaptan chez des souris pour étudier des maladies évoqués Oedème cérébral
September 1st, 2016
•